Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions - PubMed (original) (raw)

Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions

L Shi et al. J Exp Med. 1992.

Abstract

We recently reported the purification of a lymphocyte granule protein called "fragmentin," which was identified as a serine protease with the ability to induce oligonucleosomal DNA fragmentation and apoptosis (Shi, L., R. P. Kraut, R. Aebersold, and A. H. Greenberg. 1992. J. Exp. Med. 175:553). We have now purified two additional proteases with fragmentin activity from lymphocyte granules. The three proteases are of two types; one has the unusual ability to cleave a tripeptide thiobenzyl ester substrate after aspartic acid, similar to murine cytotoxic cell protease I/granzyme B, while two are tryptase-like, preferentially hydrolyzing after arginine, and bear some homology to human T cell granule tryptases, granzyme 3, and Hanukah factor/granzyme A. Using tripeptide chloromethyl ketones, the pattern of inhibition of DNA fragmentation corresponded to the inhibition of peptide hydrolysis. The Asp-ase fragmentin was blocked by aspartic acid-containing tripeptide chloromethyl ketones, while the tryptase fragmentins were inhibited by arginine-containing chloromethyl ketones. The two tryptase fragmentins were slow acting and were partly suppressed by blocking proteins synthesis with cycloheximide in the YAC-1 target cell. In contrast, the Asp-ase fragmentin was fast acting and produced DNA damage in the absence of protein synthesis. Using a panel of unrelated target cells of lymphoma, thymoma, and melanoma origin, distinct patterns of sensitivity to the three fragmentins were observed. Thus, these three granule proteases make up a family of fragmentins that activate DNA fragmentation and apoptosis by acting on unique substrates in different target cells.

PubMed Disclaimer

Cited by

The relative role of lymphocyte granule exocytosis versus death receptor-mediated cytotoxicity in viral pathophysiology.
Smyth MJ, Trapani JA. Smyth MJ, et al. J Virol. 1998 Jan;72(1):1-9. doi: 10.1128/JVI.72.1.1-9.1998. J Virol. 1998. PMID: 9420194 Free PMC article. Review. No abstract available.
Expression of granzyme B sensitizes ALK+ ALCL tumour cells to apoptosis-inducing drugs.
Pearson JD, Zhang J, Wu Z, Thew KD, Rowe KJ, Bacani JT, Ingham RJ. Pearson JD, et al. Mol Cancer. 2014 Aug 29;13:199. doi: 10.1186/1476-4598-13-199. Mol Cancer. 2014. PMID: 25168906 Free PMC article.
Lymphocyte granule-mediated cell death.
Trapani JA, Jans DA, Sutton VR. Trapani JA, et al. Springer Semin Immunopathol. 1998;19(3):323-43. doi: 10.1007/BF00787229. Springer Semin Immunopathol. 1998. PMID: 9540160 Review. No abstract available.
The natural killer cell serine protease gene Lmet1 maps to mouse chromosome 10.
Thia KY, Jenkins NA, Gilbert DJ, Copeland NG, Smyth MJ. Thia KY, et al. Immunogenetics. 1995;41(1):47-9. doi: 10.1007/BF00188433. Immunogenetics. 1995. PMID: 7806275 No abstract available.
Proteasome activities decrease during dexamethasone-induced apoptosis of thymocytes.
Beyette J, Mason GG, Murray RZ, Cohen GM, Rivett AJ. Beyette J, et al. Biochem J. 1998 Jun 1;332 ( Pt 2)(Pt 2):315-20. doi: 10.1042/bj3320315. Biochem J. 1998. PMID: 9601058 Free PMC article.

References

1. J Immunol. 1988 Nov 1;141(9):3142-7 - PubMed
1. Science. 1964 Sep 18;145(3638):1310-2 - PubMed
1. J Immunol. 1987 Nov 15;139(10):3199-206 - PubMed
1. Arch Biochem Biophys. 1959 May;82(1):70-7 - PubMed
1. J Exp Med. 1992 Feb 1;175(2):553-66 - PubMed

Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions - PubMed (original) (raw)